Holders — by stockHoldings — by fund
ADAR1 Capital Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001940272
$2.19B
disclosed book value
272
positions
11%
largest position share
Positions, as of 2026-06-30
top 100 of 272 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 1.8M | $240.5M | 11% |
| 2 | PTGXPROTAGONIST THERAPEUTICS INC | 960,863 | $117.8M | 5.4% |
| 3 | ROIVROIVANT SCIENCES LTD | 3.2M | $111.7M | 5.1% |
| 4 | SPYSTATE STR SPDR S&P 500 ETF T | 129,087 | $96.4M | 4.4% |
| 5 | IMVTIMMUNOVANT INC | 2.3M | $89.8M | 4.1% |
| 6 | ZLABZAI LAB LTD | 3.4M | $64.0M | 2.9% |
| 7 | AGIOAGIOS PHARMACEUTICALS INC | 1.3M | $47.8M | 2.2% |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 1.2M | $45.7M | 2.1% |
| 9 | BOXXEA SERIES TRUST | 337,125 | $39.5M | 1.8% |
| 10 | CYTKCYTOKINETICS INC | 457,907 | $39.0M | 1.8% |
| 11 | SEPNSEPTERNA INC | 940,747 | $31.5M | 1.4% |
| 12 | AVRANTERIS TECHNOLOGIES GLOBAL | 3.1M | $31.0M | 1.4% |
| 13 | EDITEDITAS MEDICINE INC | 8.9M | $28.8M | 1.3% |
| 14 | DNLIDENALI THERAPEUTICS INC | 1.0M | $26.5M | 1.2% |
| 15 | SYRESPYRE THERAPEUTICS INC | 283,982 | $25.2M | 1.2% |
| 16 | VIRVIR BIOTECHNOLOGY INC | 2.5M | $25.0M | 1.1% |
| 17 | PRAXPRAXIS PRECISION MEDICINES I | 74,253 | $24.9M | 1.1% |
| 18 | INSMINSMED INC | 228,520 | $24.4M | 1.1% |
| 19 | CLDXCELLDEX THERAPEUTICS INC NEW | 619,542 | $23.1M | 1.1% |
| 20 | VKTXVIKING THERAPEUTICS INC | 574,038 | $22.4M | 1% |
| 21 | TSHATAYSHA GENE THERAPIES INC | 3.0M | $20.7M | 0.9% |
| 22 | MNPRMONOPAR THERAPEUTICS INC | 217,595 | $20.1M | 0.9% |
| 23 | OVIDOVID THERAPEUTICS INC | 7.4M | $20.0M | 0.9% |
| 24 | ELVNENLIVEN THERAPEUTICS INC | 387,718 | $19.7M | 0.9% |
| 25 | ENTAENANTA PHARMACEUTICALS INC | 1.3M | $19.6M | 0.9% |
| 26 | IWMISHARES TRPUT | 62,500 | $18.8M | 0.9% |
| 27 | SPYSTATE STR SPDR S&P 500 ETF TPUT | 25,000 | $18.7M | 0.9% |
| 28 | NKTRNEKTAR THERAPEUTICS | 244,184 | $17.0M | 0.8% |
| 29 | INSPINSPIRE MED SYS INC | 374,617 | $16.7M | 0.8% |
| 30 | RVMDREVOLUTION MEDICINES INC | 87,509 | $16.4M | 0.7% |
| 31 | ESTAESTABLISHMENT LABS HLDGS INC | 185,619 | $15.9M | 0.7% |
| 32 | PRTAPROTHENA CORP PLC | 1.6M | $15.2M | 0.7% |
| 33 | RYTMRHYTHM PHARMACEUTICALS INC | 136,158 | $15.1M | 0.7% |
| 34 | IKTINHIBIKASE THERAPEUTICS INC | 7.4M | $15.0M | 0.7% |
| 35 | QUREUNIQURE NV | 324,672 | $15.0M | 0.7% |
| 36 | RLYBRALLYBIO CORP | 926,352 | $14.8M | 0.7% |
| 37 | REGNREGENERON PHARMACEUTICALS | 22,208 | $13.8M | 0.6% |
| 38 | IVAINVENTIVA SA | 3.6M | $13.6M | 0.6% |
| 39 | STROSUTRO BIOPHARMA INC | 404,014 | $13.4M | 0.6% |
| 40 | IONSIONIS PHARMACEUTICALS INC | 166,286 | $13.2M | 0.6% |
| 41 | BBIOBRIDGEBIO PHARMA INC | 176,689 | $13.2M | 0.6% |
| 42 | SRPTSAREPTA THERAPEUTICS INC | 730,649 | $13.1M | 0.6% |
| 43 | CTMXCYTOMX THERAPEUTICS INC. | 3.4M | $12.6M | 0.6% |
| 44 | VORVOR BIOPHARMA INC | 680,626 | $12.5M | 0.6% |
| 45 | BILSPDR SERIES TRUST | 135,585 | $12.4M | 0.6% |
| 46 | EQEQUILLIUM INC | 3.8M | $12.0M | 0.6% |
| 47 | ANLADLAI NORTYE LTD | 1.0M | $11.7M | 0.5% |
| 48 | CLYMCLIMB BIO INC | 822,649 | $10.7M | 0.5% |
| 49 | XBISPDR SERIES TRUSTPUT | 67,400 | $10.7M | 0.5% |
| 50 | HLXCHELIX ACQUISITION CORP III | 1.0M | $10.6M | 0.5% |
| 51 | ZURAZURA BIO LTD | 1.8M | $10.4M | 0.5% |
| 52 | OKURONKURE THERAPEUTICS INC | 2.2M | $10.2M | 0.5% |
| 53 | MAZEMAZE THERAPEUTICS INC | 339,276 | $10.1M | 0.5% |
| 54 | XENEXENON PHARMACEUTICALS INC | 166,550 | $10.1M | 0.5% |
| 55 | TEVATEVA PHARMACEUTICAL INDS LTD | 277,848 | $9.4M | 0.4% |
| 56 | URGNUROGEN PHARMA LTD | 252,395 | $9.3M | 0.4% |
| 57 | FTHFAETH THERAPEUTICS INC | 361,010 | $9.0M | 0.4% |
| 58 | AMLXAMYLYX PHARMACEUTICALS INC | 494,378 | $8.9M | 0.4% |
| 59 | DBVTDBV TECHNOLOGIES S A | 528,295 | $8.7M | 0.4% |
| 60 | SVRASAVARA INC | 1.4M | $8.6M | 0.4% |
| 61 | PCVXVAXCYTE INC | 146,034 | $8.5M | 0.4% |
| 62 | CGONCG ONCOLOGY INC | 118,664 | $8.4M | 0.4% |
| 63 | MLYSMINERALYS THERAPEUTICS INC | 298,886 | $8.1M | 0.4% |
| 64 | ASNDASCENDIS PHARMA A/S | 28,604 | $7.6M | 0.3% |
| 65 | AMANAMANAT ACQUISITION CORP | 750,000 | $7.6M | 0.3% |
| 66 | NRIXNURIX THERAPEUTICS INC | 313,236 | $7.6M | 0.3% |
| 67 | BHVNBIOHAVEN LTD | 501,687 | $7.5M | 0.3% |
| 68 | PRMEPRIME MEDICINE INC | 2.0M | $7.4M | 0.3% |
| 69 | FRNMPERCEPTIVE CAP SOLUTIONS COR | 674,695 | $7.3M | 0.3% |
| 70 | IRDOPUS GENETICS INC | 1.8M | $7.3M | 0.3% |
| 71 | LXEOLEXEO THERAPEUTICS INC | 1.6M | $7.3M | 0.3% |
| 72 | DMRADAMORA THERAPEUTICS INC | 280,000 | $7.3M | 0.3% |
| 73 | REPLREPLIMUNE GROUP INC | 655,784 | $7.3M | 0.3% |
| 74 | LONALEONABIO INC | 777,100 | $7.1M | 0.3% |
| 75 | KRROKORRO BIO INC | 540,054 | $7.1M | 0.3% |
| 76 | RACCRESEARCH ALLIANCE CORP III | 650,000 | $7.0M | 0.3% |
| 77 | IFRXINFLARX NV | 3.0M | $6.7M | 0.3% |
| 78 | RLAYRELAY THERAPEUTICS INC | 358,333 | $6.7M | 0.3% |
| 79 | JANXJANUX THERAPEUTICS INC | 420,881 | $6.5M | 0.3% |
| 80 | PLRXPLIANT THERAPEUTICS INC | 5.5M | $6.3M | 0.3% |
| 81 | WHWKWHITEHAWK THERAPEUTICS INC | 1.3M | $6.1M | 0.3% |
| 82 | KRYSKRYSTAL BIOTECH INC | 16,420 | $6.1M | 0.3% |
| 83 | ABUSARBUTUS BIOPHARMA CORP | 1.3M | $6.1M | 0.3% |
| 84 | PFEPFIZER INC | 252,400 | $6.1M | 0.3% |
| 85 | BHFBRIGHTHOUSE FINL INC | 95,523 | $6.0M | 0.3% |
| 86 | ABVXABIVAX SACALL | 44,400 | $5.9M | 0.3% |
| 87 | EWTXEDGEWISE THERAPEUTICS INC | 143,199 | $5.8M | 0.3% |
| 88 | ALECALECTOR INC | 2.9M | $5.8M | 0.3% |
| 89 | FULCFULCRUM THERAPEUTICS INC | 1.6M | $5.7M | 0.3% |
| 90 | ARWRARROWHEAD PHARMACEUTICALS IN | 69,800 | $5.7M | 0.3% |
| 91 | ABOSACUMEN PHARMACEUTICALS INC | 2.1M | $5.6M | 0.3% |
| 92 | OACCUOAKTREE ACQUISITION CORP III | 516,482 | $5.6M | 0.3% |
| 93 | GMEDGLOBUS MED INC | 70,100 | $5.5M | 0.3% |
| 94 | GLUEMONTE ROSA THERAPEUTICS INC | 216,752 | $5.2M | 0.2% |
| 95 | DGAC/UDISCIPLINED GROWTH | 500,000 | $5.0M | 0.2% |
| 96 | BHAVUBHAV ACQUISITION CORP | 495,000 | $5.0M | 0.2% |
| 97 | BBIO 1.75 03/01/31BRIDGEBIO PHARMA INC | 30,000 | $5.0M | 0.2% |
| 98 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 45,000 | $4.9M | 0.2% |
| 99 | DHRDANAHER CORP DEL | 25,932 | $4.9M | 0.2% |
| 100 | BOLDBOUNDLESS BIO INC | 2.0M | $4.9M | 0.2% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.